volume 28 issue 6 pages 455-465

A patent review of butyrylcholinesterase inhibitors and reactivators 2010–2017

Publication typeJournal Article
Publication date2018-05-31
scimago Q1
wos Q1
SJR1.200
CiteScore10.3
Impact factor4.6
ISSN13543776, 17447674
Drug Discovery
General Medicine
Pharmacology
Found 
Found 

Top-30

Journals

1
2
3
4
5
European Journal of Medicinal Chemistry
5 publications, 16.13%
Bioorganic Chemistry
4 publications, 12.9%
Current Neuropharmacology
2 publications, 6.45%
Molecules
2 publications, 6.45%
Bioorganic and Medicinal Chemistry
2 publications, 6.45%
Scientific Reports
1 publication, 3.23%
Russian Chemical Bulletin
1 publication, 3.23%
BMC Chemistry
1 publication, 3.23%
RSC Advances
1 publication, 3.23%
Mendeleev Communications
1 publication, 3.23%
Drug Discovery Today
1 publication, 3.23%
International Journal of Biological Macromolecules
1 publication, 3.23%
Chemico-Biological Interactions
1 publication, 3.23%
Chemosphere
1 publication, 3.23%
Chinese Journal of Chemistry
1 publication, 3.23%
Pharmaceutical Biology
1 publication, 3.23%
Molecular Genetics, Microbiology and Virology
1 publication, 3.23%
Russian Journal of General Chemistry
1 publication, 3.23%
Research Journal of Pharmacy and Technology
1 publication, 3.23%
1
2
3
4
5

Publishers

2
4
6
8
10
12
14
16
18
Elsevier
17 publications, 54.84%
Springer Nature
3 publications, 9.68%
Bentham Science Publishers Ltd.
2 publications, 6.45%
MDPI
2 publications, 6.45%
Pleiades Publishing
2 publications, 6.45%
Royal Society of Chemistry (RSC)
1 publication, 3.23%
Wiley
1 publication, 3.23%
Taylor & Francis
1 publication, 3.23%
A and V Publications
1 publication, 3.23%
2
4
6
8
10
12
14
16
18
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
31
Share
Cite this
GOST |
Cite this
GOST Copy
Andrisano V. et al. A patent review of butyrylcholinesterase inhibitors and reactivators 2010–2017 // Expert Opinion on Therapeutic Patents. 2018. Vol. 28. No. 6. pp. 455-465.
GOST all authors (up to 50) Copy
Andrisano V., Naldi M., De Simone A., Bartolini M. A patent review of butyrylcholinesterase inhibitors and reactivators 2010–2017 // Expert Opinion on Therapeutic Patents. 2018. Vol. 28. No. 6. pp. 455-465.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1080/13543776.2018.1476494
UR - https://doi.org/10.1080/13543776.2018.1476494
TI - A patent review of butyrylcholinesterase inhibitors and reactivators 2010–2017
T2 - Expert Opinion on Therapeutic Patents
AU - Andrisano, Vincenza
AU - Naldi, Marina
AU - De Simone, Angela
AU - Bartolini, Manuela
PY - 2018
DA - 2018/05/31
PB - Taylor & Francis
SP - 455-465
IS - 6
VL - 28
PMID - 29757691
SN - 1354-3776
SN - 1744-7674
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2018_Andrisano,
author = {Vincenza Andrisano and Marina Naldi and Angela De Simone and Manuela Bartolini},
title = {A patent review of butyrylcholinesterase inhibitors and reactivators 2010–2017},
journal = {Expert Opinion on Therapeutic Patents},
year = {2018},
volume = {28},
publisher = {Taylor & Francis},
month = {may},
url = {https://doi.org/10.1080/13543776.2018.1476494},
number = {6},
pages = {455--465},
doi = {10.1080/13543776.2018.1476494}
}
MLA
Cite this
MLA Copy
Andrisano, Vincenza, et al. “A patent review of butyrylcholinesterase inhibitors and reactivators 2010–2017.” Expert Opinion on Therapeutic Patents, vol. 28, no. 6, May. 2018, pp. 455-465. https://doi.org/10.1080/13543776.2018.1476494.